Menu
Search
|

Menu

Close
X

AxoGen Inc AXGN.OQ (NASDAQ Stock Exchange Capital Market)

54.90 USD
-- (--)
As of 1:30 AM IST
chart
Previous Close 54.90
Open --
Volume --
3m Avg Volume 100,826
Today’s High --
Today’s Low --
52 Week High 56.00
52 Week Low 14.30
Shares Outstanding (mil) 38.13
Market Capitalization (mil) 2,011.46
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.50 Mean rating from 6 analysts

KEY STATS

Revenue (mm, USD)
FY18
17
FY17
60
FY16
41
FY15
27
EPS (USD)
FY18
-0.163
FY17
-0.314
FY16
-0.465
FY15
-0.518
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
33.15
Price to Sales (TTM)
vs sector
30.74
8.04
Price to Book (MRQ)
vs sector
86.55
4.28
Price to Cash Flow (TTM)
vs sector
--
22.37
Total Debt to Equity (MRQ)
vs sector
113.34
17.43
LT Debt to Equity (MRQ)
vs sector
81.88
13.25
Return on Investment (TTM)
vs sector
-34.14
13.23
Return on Equity (TTM)
vs sector
-72.88
15.27

EXECUTIVE LEADERSHIP

Karen Zaderej
Chairman of the Board, President, Chief Executive Officer, Since 2018
Salary: $462,500.00
Bonus: $330,688.00
Peter Mariani
Chief Financial Officer, Since 2016
Salary: $336,000.00
Bonus: $147,840.00
Gregory Freitag
Senior Vice President - Business Development, General Counsel, Director, Since 2016
Salary: $189,000.00
Bonus: $83,160.00
Shawn McCarrey
Senior Vice President - Sales, Since 2013
Salary: $206,000.00
Bonus: $224,068.00
David Hansen
Vice President - Finance, Treasurer, Since 2017
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Advanced Medical Equipment & Technology
Address:

13631 Progress Blvd Ste 400
ALACHUA   FL   32615-9409

Phone: +1386.4626817

AxoGen, Inc. offers surgical solutions for peripheral nerve injuries. The Company provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. Its portfolio of products includes Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector and Avive Soft Tissue Membrane. Along with these core surgical products, the Company also offers the AxoTouch Two-Point Discriminator, and AcroVal Neurosensory and Motor Testing System. These evaluation and measurement tools assist healthcare professionals in detecting changes in sensation; assessing return of sensory, grip and pinch function; evaluating treatment interventions, and providing feedback to patients on nerve function. Its portfolio of products is available in the United States, Canada, the United Kingdom and several European and other countries. The Company's products are used by surgeons during surgical interventions to repair a range of nerve injuries throughout the body.

SPONSORED STORIES